AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avita Therapeutics

2.690

-0.130-4.61%

Volume:268.76K

Turnover:728.22K

Market Cap:354.51M

PE:-0.09

High:2.740

Open:2.740

Low:2.670

Close:2.820

Loading ...

Overview Company News Filings

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

Avita Medical Receives US FDA Approval for Wound Care Device

MT Newswires Live

ASX Market Open: Short trade day for Chrissy Eve to barely stay green after yesterday’s rocket run | Dec 24, 2024

The Market Herald

Avita Medical Receives US FDA Clearance for Wound Treatment Product

MT Newswires Live

AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

AVITA Medical, Inc. (RCEL): A Bull Case Theory

Avita Medical Signs Exclusive Deal with Australian Medical Device Distributor; Shares Up 4%

MT Newswires Live

3 exciting small cap ASX shares to buy in November

Avita Medical's Total Revenue Climbs 44% in Q3; Net Loss Widens

MT Newswires Live

AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year

Simply Wall St.

ASX Market Close: IT stocks lead bourse higher | November 8, 2024

The Market Herald

AVITA Medical (NASDAQ:RCEL) shareholders have endured a 74% loss from investing in the stock five years ago

Simply Wall St.

These small cap ASX shares could rise 25% to 100%

Buy these small cap ASX shares before interest rates fall

Top High Growth Tech Stocks To Watch In September 2024

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVH.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVH.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","market":"AU","secType":"STK","nameCN":"Avita Therapeutics","latestPrice":2.69,"timestamp":1741237920000,"preClose":2.82,"halted":0,"volume":268762,"delay":0,"changeRate":-0.046099,"change":-0.13,"floatShares":3227475,"shares":131787710,"eps":-30.155735,"lyrEps":-30.155735,"pbRate":49.95,"amount":728216,"amplitude":0.024823,"volumeRatio":1.532163,"dividePrice":0,"prevYearClose":4.25,"fiveDayClose":3.01,"twentyDayClose":3.01},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","floatShares":3227475,"roa":"-36.97%","roe":"-230.96%","lyrEps":-30.155735,"volumeRatio":1.532163,"shares":131787710,"dividePrice":0,"high":2.74,"amplitude":0.024823,"preClose":2.82,"low":2.67,"week52Low":2.34,"pbRate":"49.95","psRate":"3.50","week52High":5.17,"institutionHeld":0,"latestPrice":2.69,"committee":0.940659,"eps":-30.155735364412674,"divideRate":0,"volume":268762,"delay":0,"ttmEps":-30.155735364412674,"open":2.74,"prevYearClose":4.25,"prevWeekClose":2.85,"prevMonthClose":2.85,"prevQuarterClose":4.25,"fiveDayClose":3.01,"twentyDayClose":3.01,"sixtyDayClose":3.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVH.AU\",params:#limit:5,,,undefined,":[{"date":"2023-08-10","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1691625600000,"name":null,"time":"","dateTimestamp":1691589600000,"actualEps":null},{"date":"2023-05-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1683763200000,"name":null,"time":"","dateTimestamp":1683727200000,"actualEps":null},{"date":"2023-02-23","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677106800000,"name":null,"time":"","dateTimestamp":1677070800000,"actualEps":null},{"date":"2022-11-10","symbol":"AVH.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668034800000,"name":null,"time":"Post Market","dateTimestamp":1667998800000,"actualEps":null},{"date":"2022-08-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1660176000000,"name":null,"time":"","dateTimestamp":1660140000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVH.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVH.AU\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2493710998","title":"Guess which ASX healthcare stock is jumping 7% on US FDA approval news","url":"https://stock-news.laohu8.com/highlight/detail?id=2493710998","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493710998?lang=en_us&edition=fundamental","pubTime":"2024-12-24 07:13","pubTimestamp":1734995615,"startTime":"0","endTime":"0","summary":"AVITA Medical Inc  shares are having a strong start to the day. In morning trade, the ASX healthcare stock is up over 7% to $4.10. Why is this ASX healthcare stock jumping?The company notes that it expects RECELL GO mini to serve as a growth driver within the broader RECELL GO platform, further advancing the ASX healthcare stock's strategy to expand its impact on patient care. Its rollout will begin with trauma and burn centres that currently treat smaller wounds during the first quarter of 2025. Following today's gain, this ASX healthcare stock is now trading largely flat year to date. Though, it remains down by a sizeable 65% over the past five years.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/12/24/guess-which-asx-healthcare-stock-is-jumping-7-on-us-fda-approval-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","AVH.AU","BK7508"],"gpt_icon":0},{"id":"2493711554","title":"Avita Medical Receives US FDA Approval for Wound Care Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2493711554","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493711554?lang=en_us&edition=fundamental","pubTime":"2024-12-24 06:22","pubTimestamp":1734992571,"startTime":"0","endTime":"0","summary":"Avita Medical  received US Food and Drug Administration approval for its premarket approval supplement for the Recell Go mini, a disposable cartridge designed to treat smaller wounds up to 480 square centimeters, according to a Tuesday filing with the Australian bourse.This extends the company's Recell Go platform, which previously handled larger wounds up to 1,920 square centimeters, the filing said.The regenerative medicine company plans to roll out the product in the first quarter of 2025, targeting broader access to smaller wound care.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","AVH.AU","BK7508"],"gpt_icon":0},{"id":"2493110747","title":"ASX Market Open: Short trade day for Chrissy Eve to barely stay green after yesterday’s rocket run | Dec 24, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2493110747","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493110747?lang=en_us&edition=fundamental","pubTime":"2024-12-24 05:35","pubTimestamp":1734989700,"startTime":"0","endTime":"0","summary":"The ASX 200 is expected to stay ever so slightly in the green at open on Christmas Eve after the Wall Street Santa rush  ploughed on through weaker-than-expected U.S. consumer confidence reported on Monday.The Magnificent Seven was responsible for most of the continuing upward trends in the U.S., with the heavy-hitter tech stocks keeping the Nasdaq composite up 1%. The S&P 500 managed to stay close behind, up 0.7%.Back home, expect the ASX to close early today: Things will wrap up on the Australian bourse just after 2pm AEDT as the country prepares to celebrate Christmas. The markets will then be shut through Christmas Day and Boxing Day – the next time eager investors can make trades these holidays will be December 27.Paladin Energy  has squeezed in its $1.5 billion Fission Uranium takeover just before Christmas, confirming the major acquisition earlier today.Also just before the two-day ASX break, AVITA Medical  has scored a huge victory regarding its RECELL GO Mini disposable cartri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-open-short-trade-day-for-chrissy-eve-to-barely-stay-green-after-yesterdays-rocket-run-dec-24-2024-2024-12-24/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7067","BK7508","AVH.AU","BK7509","BK7083","PDN.AU"],"gpt_icon":0},{"id":"2492432002","title":"Avita Medical Receives US FDA Clearance for Wound Treatment Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2492432002","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492432002?lang=en_us&edition=fundamental","pubTime":"2024-12-20 09:11","pubTimestamp":1734657076,"startTime":"0","endTime":"0","summary":"Avita Medical  received a 510 clearance from the US Food and Drug Administration for Cohealyx, which is used to facilitate wound healing, according to a Friday filing with the Australian bourse.Preclinical studies in porcine models showed that Cohealyx generated strong tissue to support split-thickness skin grafts in a two-stage procedure earlier than competitors, the filing said.The company plans to develop clinical data for Cohealyx next year for its commercial launch, according to the filing. It expects to start commercialization efforts in the US in the second quarter of 2025.Shares rose more than 1% in morning trade Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVH.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2492415496","title":"AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2492415496","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492415496?lang=en_us&edition=fundamental","pubTime":"2024-12-19 05:08","pubTimestamp":1734556080,"startTime":"0","endTime":"0","summary":"VALENCIA, Calif., Dec. 18, 2024  -- AVITA Medical, Inc. , a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that Jim Corbett, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025, at 9:00 a.m. Pacific Time.About AVITA Medical, Inc.AVITA Medical is a commercial-stage regenerative medicine company transforming the standard of care in wound care management and skin restoration with innovative devices. At the forefront of our platform is the RECELL System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patient’s own skin to create Spray-On Skin Cells, delivering a transformative solution at the point-of-care. This breakthrough technology ser","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KVaCmUvLkJIoBQyoUBm6Mw--~B/aD0xMTU7dz05NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/fb4d72a9dddf2f50aa420d7ed624dbe8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KVaCmUvLkJIoBQyoUBm6Mw--~B/aD0xMTU7dz05NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/fb4d72a9dddf2f50aa420d7ed624dbe8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-present-43rd-annual-210800746.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0795875086.SGD","LU2089283258.USD","LU2089284900.SGD","LU1732800096.USD","LU0267386448.USD","LU2023251221.USD","LU0158827781.USD","BK4581","LU1363072403.SGD","LU2111349929.HKD","LU1732799900.SGD","LU0098860793.USD","LU0912757837.SGD","BK4504","HCSG","BK4516","LU1074936037.SGD","LU1668664300.SGD","BK4588","LU0971096721.USD","LU2271345857.HKD","LU0320765646.SGD","AVH.AU","LU1989772840.SGD","LU2347655156.SGD","LU2028103732.USD","LU1720051017.SGD","LU0106261372.USD","LU0158827948.USD","LU0795875169.SGD","BK4585","IE00BZ1G4Q59.USD","LU1548497426.USD","LU1162221912.USD","IE00BKVL7J92.USD","BK4139","BK4137","BK4534","LU0006306889.USD","LU0314104364.USD","LU1989772923.USD","LU2357305700.SGD","BK4127","RCEL","LU1720051108.HKD","LU0106831901.USD","LU0225283273.USD"],"gpt_icon":0},{"id":"2490009092","title":"Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490009092","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490009092?lang=en_us&edition=fundamental","pubTime":"2024-12-11 11:37","pubTimestamp":1733888272,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now.In this article, we are going to take a look at where AVITA Medical Inc.  stands against the other cosmetic surgery and aesthetics stocks.In the face of economic uncertainty, consumer preferences in the beauty industry are changing. A Bloomberg Intelligence poll conducted in June 2024 with 650 participants found that 40% of respondents gave beauty and personal care purchases more importance than other products. Nonetheless, this represents the lowest result since the survey's launch two years ago, a 10-percentage-point drop from January.In one of the recent developments, finance solutions like \"buy-now, pay-later\" loans are being given to make cosmetic procedures more affordable because of the rising demand for these procedures in the United States, as reported by Bloomberg. While the demand spike from the pandemic has subsided, rates of aesthetic procedures are still substantially high","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BnQ23IzZVkeHMe1jU9Mgcg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/25a92b3676583068e05282fcaef348f2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BnQ23IzZVkeHMe1jU9Mgcg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/25a92b3676583068e05282fcaef348f2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-avita-medical-inc-rcel-033752445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4139","RCEL","BK7067","NQmain","PSQ","TQQQ","AVH.AU","QLD","BK7508",".IXIC","SQQQ","MNQmain","QID"],"gpt_icon":1},{"id":"2488566687","title":"AVITA Medical, Inc. (RCEL): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2488566687","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488566687?lang=en_us&edition=fundamental","pubTime":"2024-12-01 08:18","pubTimestamp":1733012322,"startTime":"0","endTime":"0","summary":"We came across abullish thesison AVITA Medical, Inc.  on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc. 's share was trading at $12.89 as of Nov 26th.A doctor and a patient discussing a therapy plan that includes pharmaceutical products.Avita Medical  recently announced strong Q3 2024 financial results and provided business updates that highlight its promising growth trajectory and potential. The company reported commercial revenue of $19.5 million, reflecting a robust 44% year-over-year increase, and an impressive gross profit margin of 83.7%. Although slightly down from the prior year due to engineering and validation costs for the RECELL GO platform, these margins remain exceptional for a company of Avita’s scale. With a cash position of $44.4 million as of September 30, 2024, Avita is well-positioned to execute on its strategic initiatives.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PJnmbMxgWgEfNsy0OCh2_w--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bd0c0be3672e5f6896f5e2ef5c748a51","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PJnmbMxgWgEfNsy0OCh2_w--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bd0c0be3672e5f6896f5e2ef5c748a51"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-inc-rcel-bull-001842373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","RCEL","AVH.AU"],"gpt_icon":0},{"id":"2483101366","title":"Avita Medical Signs Exclusive Deal with Australian Medical Device Distributor; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483101366","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483101366?lang=en_us&edition=fundamental","pubTime":"2024-11-13 10:25","pubTimestamp":1731464727,"startTime":"0","endTime":"0","summary":"Avita Medical  signed an exclusive agreement with Revolution Surgical for the distribution of the Recell product platform for thermal burn wound treatment, according to a Wednesday filing with the Australian bourse.Revolution Surgical will be the exclusive distributor of Recell products in Australia and New Zealand under the deal, the filing said.Avita Medical shares rose nearly 4% in midday trade Wednesday.Price : $3.81, Change: $+0.13, Percent Change: +3.53%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0994945656.USD","XJO.AU","BK7508","LU0426412945.USD","LU0345774631.USD","LU2238339852.HKD","AVH.AU","LU0426417589.USD","BK4125","LU1043141123.HKD","XAO.AU","XKO.AU","AUD","BK7067"],"gpt_icon":0},{"id":"2483998054","title":"3 exciting small cap ASX shares to buy in November","url":"https://stock-news.laohu8.com/highlight/detail?id=2483998054","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483998054?lang=en_us&edition=fundamental","pubTime":"2024-11-13 04:24","pubTimestamp":1731443094,"startTime":"0","endTime":"0","summary":"If you are a fan of small cap ASX shares, then you will be pleased to know that analysts have recently named a number as buys. Here's what you need to know about these shares from the small side of th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/13/3-exciting-small-cap-asx-shares-to-buy-in-november/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7078","BK7508","BBT.AU","RDY.AU","BK7016","AVH.AU","BK7067"],"gpt_icon":0},{"id":"2482902322","title":"Avita Medical's Total Revenue Climbs 44% in Q3; Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2482902322","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482902322?lang=en_us&edition=fundamental","pubTime":"2024-11-11 06:22","pubTimestamp":1731277353,"startTime":"0","endTime":"0","summary":"Avita Medical  reported a net loss of $16.2 million, or $0.62 per share, for the third quarter, compared with a net loss of $8.7 million, or $0.34 per share, a year ago, according to a Nov. 8 filing with the Australian bourse.Total revenue for the three months ended Sept. 30 was $19.5 million, an increase of 44% from $13.6 million in the year-ago period on the strength of Avita's cell harvesting device, Recell GO.The regenerative medicine company expects commercial revenue for the fourth quarter to rise 58% to 72% year on year to a range of $22.3 million to $24.3 million.Fiscal 2024 revenue is expected to be within the previous guidance of $68 million to $70 million, reflecting an annual increase of 37% to 41%. The company also reaffirmed guidance of achieving cashflow break-even and GAAP profitability no later than the end of the third quarter of fiscal 2025, the filing stated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVH.AU","TSS"],"gpt_icon":0},{"id":"2482594428","title":"AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2482594428","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482594428?lang=en_us&edition=fundamental","pubTime":"2024-11-09 21:05","pubTimestamp":1731157503,"startTime":"0","endTime":"0","summary":"Shareholders of AVITA Medical, Inc.  will be pleased this week, given that the stock price is up 16% to US$11.95 following its latest quarterly results. It was a pretty bad result overall; while revenues were in line with expectations at US$20m, statutory losses exploded to US$0.64 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.NasdaqCM:RCEL Earnings and Revenue Growth November 9th 2024. The most important thing to note is the forecast of increased losses next year, suggesting all may not be well at AVITA Medical. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was no real change to the consensus price target, sugge","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-inc-nasdaq-rcel-130503274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585",".IXIC","AVH.AU","SQQQ","RCEL","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","QLD","BK4588","LU2210149790.SGD","QID","NQmain","MNQmain","PSQ","IE00B3QW5Z07.USD","BK4139","LU2095319765.USD","TQQQ","NDAQ","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2481111300","title":"ASX Market Close: IT stocks lead bourse higher  | November 8, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481111300","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481111300?lang=en_us&edition=fundamental","pubTime":"2024-11-08 13:59","pubTimestamp":1731045540,"startTime":"0","endTime":"0","summary":"The market remains buoyant in the wake of Trump’s election in the United States, and the expectation China will ramp up stimulus measures.IT finished the session the best performing sector, up 1.76%, followed by Discretionary, up 1.3%, and Real Estate, up 1.2%.Australia’s biggest company Commonwealth Bank  closed up 1.4% after hitting a new all time intra-day record. The company remains in favour with investors, despite a historically high price to earnings ratio of 26.5.Sigma Healthcare  closed up 4.53% as analysts price in ACCC approval for the multi billion dollar merger with Chemist Warehouse. Citi expects the combined entity to continue performing well and says there is opportunity for international expansion.Equinox Resources closed up 32% on reports of “ultra high grade” antimony at its Canadian Alturas project. Assayed samples flagged on Friday included two just shy of 70%; and several hovering just under 50%.SSR Mining  closed down 11.76% on release of its quarterlies. The com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-it-stocks-lead-bourse-higher-november-8-2024-2024-11-08/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["CBA.AU","EQN.AU","BK7135","BK7508","BK7103","BK7104","SIG.AU","BK7067","BK7033","BK7158","AVH.AU","SQ2.AU","BK7506","SSR.AU","BK7129"],"gpt_icon":0},{"id":"2474411728","title":"AVITA Medical (NASDAQ:RCEL) shareholders have endured a 74% loss from investing in the stock five years ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2474411728","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474411728?lang=en_us&edition=fundamental","pubTime":"2024-10-10 23:05","pubTimestamp":1728572753,"startTime":"0","endTime":"0","summary":"While not a mind-blowing move, it is good to see that the AVITA Medical, Inc.  share price has gained 15% in the last three months. But that doesn't change the fact that the returns over the last half decade have been stomach churning. Like a ship taking on water, the share price has sunk 74% in that time. While the recent increase might be a green shoot, we're certainly hesitant to rejoice. The million dollar question is whether the company can justify a long term recovery.It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.AVITA Medical isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally hope to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit gro","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-nasdaq-rcel-shareholders-150553631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["QLD","TQQQ","MNQmain","RCEL",".IXIC","BK7508","BK4585","LU2210150020.SGD","PSQ","SQQQ","BK7067","QID","LU2095319765.USD","IE00B64PRP62.GBP","BK4588","NQmain","LU2210149790.SGD","NDAQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4139","BK4112","IE00BGHQF748.EUR","AVH.AU"],"gpt_icon":1},{"id":"2473458176","title":"These small cap ASX shares could rise 25% to 100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473458176","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473458176?lang=en_us&edition=fundamental","pubTime":"2024-10-08 06:57","pubTimestamp":1728341820,"startTime":"0","endTime":"0","summary":"Investors that are looking for exposure to the small side of the market, might want to check out the small cap ASX shares listed below. That's because they were recently named as buys by brokers and t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/10/08/these-small-cap-asx-shares-could-rise-25-to-100/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7055","BK7067","BK7508","AVH.AU","BK7161","SRG.AU","PC","CHL.AU","BK4209"],"gpt_icon":1},{"id":"2470424666","title":"Buy these small cap ASX shares before interest rates fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2470424666","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470424666?lang=en_us&edition=fundamental","pubTime":"2024-09-25 07:44","pubTimestamp":1727221480,"startTime":"0","endTime":"0","summary":"Many analysts believe that interest rate cuts will put a rocket under small cap ASX shares, which have been underperforming during the rate hike cycle. And while Australian interest rates may not be heading lower until next year, it could pay for investors to get in early with small caps. But which small cap ASX shares could be buys before interest rates fall?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/09/25/buy-these-small-cap-asx-shares-before-interest-rates-fall/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["AVH.AU","BK7110","BK7067","BK7508","AIS.AU"],"gpt_icon":1},{"id":"2467779785","title":"Top High Growth Tech Stocks To Watch In September 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2467779785","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467779785?lang=en_us&edition=fundamental","pubTime":"2024-09-13 22:05","pubTimestamp":1726236337,"startTime":"0","endTime":"0","summary":"The market is up 1.6% over the last week, with the Information Technology sector up 4.2%. In the last year, the market has climbed 22%, and earnings are forecast to grow by 15% annually. In this thriving environment, identifying high-growth tech stocks that align with these optimistic trends can be crucial for investors looking to capitalize on future opportunities.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 251 stocks from our US High Growth Tech and AI Stocks screener.NasdaqCM:RCEL Earnings and Revenue Growth as at Sep 2024. Overview: Verra Mobility Corporation offers smart mobility technology solutions and services across the United States, Australia, Canada, and Europe, with a market cap of $4.45 billion.Operations: Verra Mobility generates revenue primarily from three segments: Parking Solutions , Commercial Services , and Government Solutions . The company's offerings span multiple regions, including the United States, Australia, Can","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/jtwePbKEAZvFHrncXoq7iQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/ee047812921f935c11e8b8a18a28c857","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/jtwePbKEAZvFHrncXoq7iQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/ee047812921f935c11e8b8a18a28c857"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-high-growth-tech-stocks-140537745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VRRM","AVH.AU","BK4077","RCEL","TBLA","TBLAW"],"gpt_icon":1}],"pageSize":16,"totalPage":3,"pageCount":2,"totalSize":33}]}}